Clinical Trials Search at Vanderbilt-Ingram Cancer Center

PROTECT IV - Impella-Supported PCI in High-Risk Patients with Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial

Disease Sites:

Not Available

Staging:

Phase III

Age Group:

Adults

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Barker, Colin

Scope:

International

Participating Institutions:

Vanderbilt University

Open Date:

06-10-2022

Trial Type:

Treatment

Protocol ID:

CRE-INT0006

National Clinical Trial ID:

NCT04763200

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available